Tirzepatide is a cutting-edge dual GLP-1 and GIP receptor agonist designed to deliver powerful appetite suppression, improved insulin sensitivity, and accelerated fat loss. Unlike standard peptides that require mixing, this pre-filled aqueous pen comes fully dissolved and ready to use — simply dial your dose, click, and inject subcutaneously.

Key Features

• Fully premixed: no vials, no reconstitution; immediate use.
• Dual-incretin mechanism: synergistic GLP-1 & GIP activation for superior metabolic effects.
• Precision dosing: micro-dial system; each click delivers 0.1 mg, with a clear window showing the remaining solution.
• Capacity: 300 clicks × 0.1 mg = 30 mg total.
• Quality & Safety: ≥ 99% purity, endotoxin < 0.03 EU/mg, sterilized, tamper-evident, and scratch-code verified.

Titration Schedule 

The typical maintenance dosage is 5 mg, 10 mg, or 15 mg.

Pen Usage by Dose

• 2.5 mg weekly → 12 weeks per pen
• 5 mg weekly → 6 weeks per pen
• 7.5 mg weekly → 4 weeks per pen
• 10 mg weekly → 3 weeks per pen
• 12.5 mg weekly → 2.4 weeks per pen
• 15 mg weekly → 2 weeks per pen

Notes:

• Always escalate gradually (every 4 weeks) to reduce GI side effects.
• Skip escalation if the current dose is well-tolerated but effective.
• Administer once weekly, same day each week, subcutaneously in the abdomen, thigh, or upper arm.

• Refrigerate at 35-40°F after opening.
• Stable for 30 days when stored at 35-40°F

Administration Guide

Tirzepatide Pre-filled Pen (30 mg) Administration Guide